Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TC Biopharm (Holdings) ( (TCBPY) ) has provided an update.
On August 29, 2025, TC BioPharm (Holdings) plc held its 2025 Annual General Meeting where all proposed resolutions were passed. Key resolutions included the approval of the company’s 2024 annual report, the reappointment of Ecovis Wingrave Yeats as the statutory auditor, and the authorization for the directors to allot shares up to £200 million. Additionally, the company approved a share subdivision and reclassification, introducing B Deferred Shares with specific rights and restrictions. These decisions aim to strengthen the company’s financial structure and provide flexibility for future capital raising, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (TCBPY) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on TC Biopharm (Holdings) stock, see the TCBPY Stock Forecast page.
Spark’s Take on TCBPY Stock
According to Spark, TipRanks’ AI Analyst, TCBPY is a Underperform.
TC Biopharm’s overall score is primarily impacted by its weak financial performance, characterized by declining revenues and negative cash flow. Technical analysis indicates bearish momentum, while the absence of valuation metrics and earnings call information limits positive insights. The stock’s financial instability and operational inefficiencies are major concerns.
To see Spark’s full report on TCBPY stock, click here.
More about TC Biopharm (Holdings)
TC BioPharm (Holdings) plc is a company operating in the biotechnology industry, focusing on developing cell-based therapies for cancer treatment. The company is based in Scotland, United Kingdom, and is involved in innovative medical research and development.
Average Trading Volume: 8,250
Technical Sentiment Signal: Sell
Current Market Cap: $211.7K
For an in-depth examination of TCBPY stock, go to TipRanks’ Overview page.